InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Nkarta, Inc.

NKTX Clue Score29
United States Fiscal year ends December CIK 0001787400 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

90
Insider
Date
Role
Action
Shares
Price
Amount
Paul J Hastings
18 Jun 2026
Chief Executive Officer
Sell
1,776
$2.71
$4.81K
Nadir Mahmood
15 Jan 2026
President
Sell
5,649
$2.07
$11.69K
Paul J Hastings
15 Jan 2026
Chief Executive Officer
Sell
26,046
$2.07
$53.92K
Paul J Hastings
18 Jun 2025
Chief Executive Officer
Sell
1,790
$1.79
$3.20K
Alicia J. Hager
15 Jan 2025
Chief Legal Officer
Sell
9,584
$2.20
$21.08K
Paul J Hastings
15 Jan 2025
Chief Executive Officer
Sell
17,378
$2.20
$38.23K
Ralph Brandenberger
15 Jan 2025
Chief Technical Officer
Sell
7,447
$2.20
$16.38K
Alyssa Levin
15 Jan 2025
See Remarks
Sell
5,838
$2.20
$12.84K
David Shook
15 Jan 2025
See Remarks
Sell
8,638
$2.20
$19.00K
Alicia J. Hager
16 Jul 2024
Chief Legal Officer
Sold on a plan
3,396
$8.00
$27.17K
Ralph Brandenberger
18 Jun 2024
Chief Technical Officer
Sell
229
$5.60
$1.28K
Alicia J. Hager
18 Jun 2024
Chief Legal Officer
Sell
727
$5.60
$4.07K
David Shook
18 Jun 2024
Chief Medical Officer
Sell
456
$5.60
$2.55K
Paul J Hastings
18 Jun 2024
Chief Executive Officer
Sell
1,770
$5.60
$9.91K
James Trager
18 Jun 2024
Chief Scientific Officer
Sell
456
$5.60
$2.55K
Simeon George
27 Mar 2024
Director
Buy indirect
451,659
$10.00
$4.52M
Simeon George
27 Mar 2024
Director
Buy indirect
1,548,341
$10.00
$15.48M
Ra Capital Management, L.p.
27 Mar 2024
Director
Buy indirect
3,000,000
$10.00
$30.00M
Ralph Brandenberger
1 Mar 2024
Chief Technical Officer
Sold after exercise
8,367
$12.51
$104.67K
James Trager
12 Feb 2024
Chief Scientific Officer
Sell
4,143
$12.00
$49.72K
Alicia J. Hager
16 Jan 2024
Chief Legal Officer
Sell
4,554
$8.74
$39.80K
Paul J Hastings
16 Jan 2024
Chief Executive Officer
Sell
9,697
$8.74
$84.75K
Ralph Brandenberger
16 Jan 2024
Chief Technical Officer
Sell
2,512
$8.74
$21.95K
James Trager
16 Jan 2024
Chief Scientific Officer
Sell
4,560
$8.74
$39.85K
David Shook
16 Jan 2024
Chief Medical Officer
Sell
3,552
$8.74
$31.04K
David Shook
21 Aug 2023
Chief Medical Officer
Sell
1,331
$1.83
$2.44K
Paul J Hastings
20 Jun 2023
Chief Executive Officer
Sell
1,704
$4.85
$8.26K
Nadir Mahmood
20 Jun 2023
See Remarks
Sell
526
$4.85
$2.55K
David Shook
20 Jun 2023
Chief Medical Officer
Sell
439
$4.85
$2.13K
Alicia J. Hager
20 Jun 2023
Chief Legal Officer
Sell
701
$4.85
$3.40K
Ralph Brandenberger
20 Jun 2023
Chief Technical Officer
Sell
221
$4.85
$1.07K
James Trager
20 Jun 2023
Chief Scientific Officer
Sell
439
$4.85
$2.13K
Ralph Brandenberger
17 Jan 2023
Chief Technical Officer
Sell
491
$5.49
$2.70K
Alicia J. Hager
17 Jan 2023
Chief Legal Officer
Sell
1,103
$5.49
$6.06K
Paul J Hastings
17 Jan 2023
Chief Executive Officer
Sell
3,691
$5.49
$20.26K
Nadir Mahmood
17 Jan 2023
See Remarks
Sell
1,122
$5.49
$6.16K
David Shook
17 Jan 2023
Chief Medical Officer
Sell
175
$5.49
$960.75
James Trager
17 Jan 2023
Chief Scientific Officer
Sell
1,115
$5.49
$6.12K
Ralph Brandenberger
6 Oct 2022
Chief Technical Officer
Sold after exercise
842
$14.02
$11.80K
Paul J Hastings
29 Sep 2022
Chief Executive Officer
Sell
498
$13.00
$6.47K
Paul J Hastings
28 Sep 2022
Chief Executive Officer
Sell
23,376
$13.03
$304.61K
Paul J Hastings
21 Sep 2022
Chief Executive Officer
Sell
6,126
$13.01
$79.72K
Nadir Mahmood
15 Aug 2022
See Remarks
Sold after exercise
7,500
$18.03
$135.22K
Ralph Brandenberger
15 Aug 2022
Chief Technical Officer
Sold after exercise
11,000
$17.64
$194.05K
James Trager
15 Aug 2022
Chief Scientific Officer
Sold after exercise
5,000
$17.53
$87.66K
Nadir Mahmood
8 Aug 2022
See Remarks
Sold after exercise
7,500
$15.32
$114.90K
Ralph Brandenberger
8 Aug 2022
Chief Technical Officer
Sold after exercise
11,593
$15.51
$179.78K
Nadir Mahmood
25 Jul 2022
See Remarks
Sold after exercise
7,500
$13.40
$100.48K
Ralph Brandenberger
25 Jul 2022
Chief Technical Officer
Sold after exercise
3,000
$13.41
$40.23K
Ralph Brandenberger
3 Jun 2022
Sr. VP, Technical Operations
Sold after exercise
4,140
$15.00
$62.10K
Simeon George
28 Apr 2022
Director
Buy indirect
666,666
$15.00
$10.00M
Simeon George
28 Apr 2022
Director
Buy indirect
666,667
$15.00
$10.00M
Ra Capital Management, L.p.
26 Apr 2022
Director
Buy indirect
2,200,000
$15.00
$33.00M
Ralph Brandenberger
1 Dec 2021
Sr. VP, Technical Operations
Sold after exercise
4,140
$15.64
$64.75K
Paul J Hastings
29 Sep 2021
Chief Executive Officer
Sell
223
$26.53
$5.92K
Paul J Hastings
29 Sep 2021
Chief Executive Officer
Sell
8,277
$27.20
$225.13K
Ralph Brandenberger
1 Sep 2021
See Remarks
Sold after exercise
4,140
$32.08
$132.81K
Kanya Rajangam
5 Aug 2021
Chief Medical Officer
Sold after exercise
10,000
$37.28
$372.80K
James Trager
2 Aug 2021
Chief Scientific Officer
Sold after exercise
3,600
$31.53
$113.51K
Nadir Mahmood
1 Jul 2021
See Remarks
Sold after exercise
6,500
$31.71
$206.12K
Paul J Hastings
21 Jun 2021
Chief Executive Officer
Sell
3,807
$26.89
$102.37K
Paul J Hastings
21 Jun 2021
Chief Executive Officer
Sell
4,693
$26.39
$123.85K
Nadir Mahmood
16 Jun 2021
See Remarks
Exercised, kept
1,800
$3.89
$7.00K
Ralph Brandenberger
2 Jun 2021
See Remarks
Sold after exercise
4,140
$24.50
$101.43K
Nadir Mahmood
10 May 2021
See Remarks
Sell
3,000
$27.16
$81.48K
James Trager
3 May 2021
Chief Scientific Officer
Sold after exercise
2,250
$31.64
$71.19K
James Trager
3 May 2021
Chief Scientific Officer
Sold after exercise
1,350
$31.64
$42.71K
Nadir Mahmood
1 Apr 2021
See Remarks
Sold after exercise
3,500
$32.70
$114.45K
Paul J Hastings
30 Mar 2021
Chief Executive Officer
Sell
3,130
$32.21
$100.82K
Paul J Hastings
30 Mar 2021
Chief Executive Officer
Sell
2,409
$31.24
$75.26K
Paul J Hastings
30 Mar 2021
Chief Executive Officer
Sell
11,461
$30.23
$346.47K
James Trager
2 Feb 2021
Chief Scientific Officer
Sold after exercise
2,800
$40.00
$112.00K
James Trager
1 Feb 2021
Chief Scientific Officer
Sold after exercise
1,566
$39.46
$61.79K
James Trager
1 Feb 2021
Chief Scientific Officer
Sold after exercise
2,034
$38.07
$77.43K
Nadir Mahmood
25 Jan 2021
See Remarks
Sold after exercise
3,500
$48.40
$169.40K
Nadir Mahmood
25 Jan 2021
See Remarks
Sold after exercise
2,000
$48.86
$97.72K
Nadir Mahmood
14 Jan 2021
See Remarks
Exercised, kept
3,083
$3.89
$11.99K
Nadir Mahmood
3 Dec 2020
See Remarks
Exercised, kept
3,000
$3.89
$11.67K
James E Flynn
14 Jul 2020
10% owner
Buy indirect
500,000
$18.00
$9.00M
James E Flynn
14 Jul 2020
10% owner
Buy indirect
500,000
$18.00
$9.00M
Ra Capital Management, L.p.
14 Jul 2020
10% owner
Buy indirect
3,333,333
$18.00
$60.00M
Novo Holdings A/S
14 Jul 2020
10% owner
Buy
555,555
$18.00
$10.00M
Anthony A. Florence Jr.
14 Jul 2020
10% owner
Buy indirect
666,666
$18.00
$12.00M
Forest Baskett
14 Jul 2020
10% owner
Buy indirect
666,666
$18.00
$12.00M
Joshua Makower
14 Jul 2020
10% owner
Buy indirect
666,666
$18.00
$12.00M
Mohamad Makhzoumi
14 Jul 2020
10% owner
Buy indirect
666,666
$18.00
$12.00M
Peter W. Sonsini
14 Jul 2020
10% owner
Buy indirect
666,666
$18.00
$12.00M
Scott D Sandell
14 Jul 2020
10% owner
Buy indirect
666,666
$18.00
$12.00M
New Enterprise Associates 15, L.P.
14 Jul 2020
10% owner
Buy
666,666
$18.00
$12.00M
GSK plc
14 Jul 2020
Director
Buy indirect
833,333
$18.00
$15.00M

What was left out

Form 4 filings counted 184
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 11
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 24
Sales at will 44
Transactions with no price 0
Shares from compensation/vesting 26,112,417
Sales filed before the plan box existed 17
History held since 13 Jul 2020